These compounds may interact with:
Hepatocyte growth factor receptor
Potentially involved in: nonsyndromic deafness; lung cancer; cancer; breast cancer; multiple sclerosis; kidney cancer; carcinoma; liver cancer; large intestine cancer; upper respiratory tract disease; ensp00000256078; autosomal recessive nonsyndromic deafness 97; liver disease; adenocarcinoma; astrocytoma; autistic disorder; non-small cell lung carcinoma; renal cell carcinoma; squamous cell carcinoma; cognition disorders
Disease data sourced from Pharos.